Teligent SG&A Expenses 2010-2021 | TLGT
Teligent sg&a expenses from 2010 to 2021. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Teligent Annual SG&A Expenses
(Millions of US $) |
| 2020 |
$27 |
| 2019 |
$21 |
| 2018 |
$23 |
| 2017 |
$20 |
| 2016 |
$15 |
| 2015 |
$11 |
| 2014 |
$6 |
| 2013 |
$3 |
| 2012 |
$3 |
| 2011 |
$3 |
| 2010 |
$3 |
| 2009 |
$4 |
Teligent Quarterly SG&A Expenses
(Millions of US $) |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$6 |
| 2020-12-31 |
$9 |
| 2020-09-30 |
$7 |
| 2020-06-30 |
$5 |
| 2020-03-31 |
$7 |
| 2019-12-31 |
$5 |
| 2019-09-30 |
$5 |
| 2019-06-30 |
$5 |
| 2019-03-31 |
$6 |
| 2018-12-31 |
$7 |
| 2018-09-30 |
$5 |
| 2018-06-30 |
$6 |
| 2018-03-31 |
$5 |
| 2017-12-31 |
$5 |
| 2017-09-30 |
$6 |
| 2017-06-30 |
$5 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$4 |
| 2016-06-30 |
$4 |
| 2016-03-31 |
$3 |
| 2015-12-31 |
$5 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$2 |
| 2014-12-31 |
$2 |
| 2014-09-30 |
$1 |
| 2014-06-30 |
$1 |
| 2014-03-31 |
$1 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$1 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$1 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
